Next generation sequencing: implications in personalized medicine and pharmacogenomics
- 29 March 2016
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Molecular BioSystems
- Vol. 12 (6), 1818-1830
- https://doi.org/10.1039/c6mb00115g
Abstract
A breakthrough in next generation sequencing (NGS) in the last decade provided an unprecedented opportunity to investigate genetic variations in humans and their roles in health and disease. NGS offers regional genomic sequencing such as whole exome sequencing of coding regions of all genes, as well as whole genome sequencing. RNA-seq offers sequencing of the entire transcriptome and ChIP-seq allows for sequencing the epigenetic architecture of the genome. Identifying genetic variations in individuals can be used to predict disease risk, with the potential to halt or retard disease progression. NGS can also be used to predict the response to or adverse effects of drugs or to calculate appropriate drug dosage. Such a personalized medicine also provides the possibility to treat diseases based on the genetic makeup of the patient. Here, we review the basics of NGS technologies and their application in human diseases to foster human healthcare and personalized medicine.This publication has 127 references indexed in Scilit:
- Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypesDiabetologia, 2012
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Single Molecule Sequencing with a HeliScope Genetic Analysis SystemCurrent Protocols in Molecular Biology, 2010
- Clinical assessment incorporating a personal genomeThe Lancet, 2010
- ChIP-seq: Using high-throughput sequencing to discover protein–DNA interactionsMethods, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Integration of cytogenetic landmarks into the draft sequence of the human genomeNature, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Initial sequencing and analysis of the human genomeNature, 2001